Nimbus Synergies

As a Venture Capital Management firm founded in 2008, we've honed our expertise in Health Technologies: biotech, medical devices and digital health. Founded in 2008 by our seasoned, multi-disciplinary executive team and headquartered in Madrid and Barcelona, we are best positioned to reach most vibrant innovation hubs across Europe. We are at the intersection between… Science and Technology: We harness the power of scientific research and technological innovation to advance healthcare. Ventures and Innovation: We back visionary entrepreneurs and innovative ventures that are transforming the healthcare landscape. Digital and Healthcare: Embracing new digital technologies to enhance people's health.

Healthcare in India is a broken experience for most patients. Challenges of access, quality of care and non-holistic solutions exist across patient demographics At 2070 Health, we aim to strike at the heart of the problem by addressing the challenges that hinder innovation in this industry and solve for the massive white spaces We are India’s first Venture Studio building patient-centric healthcare companies from scratch by bringing together futuristic ideas, exceptional founders, and a powerful innovation platform Building a series of ventures from concept to scale Our proven 4-step process lets us replicate success across ventures. Through research-driven concepts and an expert-led approach, we’re able to build and scale sustainable companies STEP 1: Ideation & deep validation We discover disruptive opportunities through fundamental research and deep diligence. We kill 90% ideas with conviction through a structured research process, and introducing several stage gates before the idea sees the light of day ​ STEP 2: Team Building We set the business up for success by bringing in exceptional founders and early team. We are building India's largest talent universe with thousands of potential founders, to create a pipeline of rockstar business leaders STEP 3: Launch We expedite growth via our powerful Innovation Platform: technology stack, omnichannel GTM capabilities, marketing expertise, talent ecosystem, powerful partnerships, and capital​ STEP 4: Scale Up We leverage functional playbooks across Tech, Growth, Marketing, Finance, Legal & Regulatory, etc. to support growth, till the company reaches maturity​ Innovation. Impact. Healthcare.Respect: We will treat each other with respect. Every individual will be valued for their unique contributions and everyone will be treated with fairness, and compassion Honesty: We will be honest in our words and actions --- do right by others, have a backbone, and speak up Action: We will have an insatiable, no-nonsense drive for action and accountability. We will take prompt and decisive actions in the face of uncertainty or ambiguity Collaboration: We recognize that our vision of transforming healthcare is a monumental one, and cannot be achieved by individual efforts until we leverage the power of the team Positivity: We will stay focused, agile, and positive even in tough times. We will learn from failures, and will be relentless in our pursuit of excellence. Giving up is never an option Innovation: We will ideate & innovate with boldness & courage as we venture on ‘the road not taken’

As an evergreen investment firm, we support entrepreneurs in the digital, healthcare and deeptech sectors by mobilizing our €500 million of permanent capital to provide value in their growth expansion phase. We provide our network of SMEs and SMIs with strong regional roots to the managers we support while giving them the benefit of our direct international presence in Europe and North America. It gives to our client the opportunity to grow more rapidly at an international scale with specialists of their business sector.

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.

We're looking for the rebels. We invest in the underdogs. The contrarians. The resilient. We want to write the untold stories that rewire prevailing ways of thinking and doing. We’re a VC firm that helps build, not bet on, companies transforming massive industries. We started from an MIT dorm room during the Great Recession and spent the last decade helping build industry-leading companies, often bringing them their biggest, million-dollar customers. Everyone told us we were crazy when we got started. Now we have offices in Boston, San Francisco, and London. We like defying the crowd, following our instincts, and proving them wrong. We love if you do too. We admire people who think really big. Those who want to craft legendary, contrarian companies worth $5B or more. Those who have an irrational belief in your vision. We are very patient and have both youth and experience on our side, and we are hungry to build. We lead Seed, Series A, and early Series B rounds. We prefer B2B companies tackling large traditional industries and/or commercializing research from top-tier groups. We are generalist, but themes that excite us include: human-machine convergence (augmentation and automation) consumer-enterprise interface (digitalization of the consumer experience) enterprise agility (‘real-time’ actionable insights from novel data sources) new industrial revolution (use of sensors and software in industry) security of all data (more digitalization, more security problems) software eating healthcare (making delivery more accurate, efficient, efficacious) generation Z (the future) How much are you looking to raise?$0 - 3M (Pre-Seed / Seed): We write small checks into multiple companies at the Seed stage. Our goal is to work closely with you to determine whether we should continue our investment at the Series A. Historically, we have achieved a 2:1 ratio in terms of Seed investments to Series A follow-on rounds. $3 - 10M (Series A): We lead $3-10M rounds at the Series A stage. Our core investments are either follow-on investments from companies we’ve seeded or first checks into new additions to our portfolio. As the lead institutional investor in your company, we will work closely with your executive team and board and serve as a true partner in your growth. $10 - 20M (Series B): We lead $10-20M rounds at the Series B stage. A portion of these investments will be follow-ons from our Series A companies, but many will be new additions to our portfolio. We partner with entrepreneurs who are uninterested in raising artificially inflated rounds and who seek active partners to help hire executives, build boards, and optimize growth strategy. How we help We don’t bet. We build – and that starts from our first interaction with each entrepreneur. We work tirelessly to add value to the companies in our portfolio, and we base that strategy around four core pillars. Customer Acquisition: We help you kick down doors, secure early pilots, and win contracts with key customers. Building Go-to-Market Teams: We work closely with you to find and win the best talent for your most critical roles. Fundraising Strategies: We guide you as you prepare and pursue additional capital to build and grow. Board-Level Strategy: We support you in making decisions as an experienced voice at the table, and we bring in other players who can add outsized value.

We believe that the future of modern healthcare is led by a digital revolution. Investing in solutions that help to transforms these challenges healthcare is facing. When technology is fuelled by digitalisation, innovation will thrive and grow, creating leverage for global reform. By supporting innovative digital-health startups with seed capital, extensive industry knowledge and a powerful global network, we aim to change the future of healthcare forever. Entrepreneurial capital: Our work is rooted in a deep understanding of the system in which we operate. Pioneering: We believe that the future of modern healthcare is led by a digital revolution. Committed to impact: There is an idealistic element to our proposition. The aim of our efforts is change. Human centred: People are at the core of everything we do. They are the end to our means and the why to our what. From a business perspective this translates into a strong desire to invest in a team, rather than a business plan. We believe in long term shared success. The Approach In return for the invested capital and support, Healthy.Capital acquires a minority share. We are: Team with experts Entrepreneurs by heart Specialist in building product-market fit Long term investment relationships Digital Health VC with international network Ecosystem key player Our initially invested capital ranges between EUR 200K and EUR 1 M. Once a board, and depending on the proposition, we will offer support with a startup mentality in the following areas: Strategy Building Coaching Operational Expertise Business Development Health & Care Expertise Co-investments Financial Roadmap Planning Network Expansion Healthy.Capital invests in talented founders & teams. Our focus is Digital Health Solutions Services SaaS Marketplaces Our Criteria Business entity registered in the Netherlands Company younger than 7 years old Tech component (pre-)Seed stage Excellent teams Data driven DNA Strong problem-solution fit High scalability with healthy profitability